Curcumin inhibits the proliferation of airway smooth muscle cells in vitro and in vivo

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 629-636

  Zeng, Xin ^a   Cheng, Ying ^a   Qu, Yuejun ^a   Xu, Jide ^a   Han, Zhiyuan ^a   Zhang, Tingting ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Airway remodeling; Airway smooth muscle cells; Asthma; Caveolin 1; Curcumin; Extracellular signal regulated kinase 1 2; Proliferation

Indexed keywords

CAVEOLIN 1; CURCUMIN; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR;

AIRWAY; AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASTHMA; CAVEOLA; CELL INFILTRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPHORIA; DYSPNEA; ENZYME PHOSPHORYLATION; FEMALE; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MOUSE; MUSCLE SPASM; MUSCLE THICKNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SMOOTH MUSCLE FIBER; TACHYPNEA; WESTERN BLOTTING;

AIRWAY REMODELING; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BRONCHI; CAVEOLIN 1; CELL PROLIFERATION; CURCUMIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; LUNG; MICE; MYOCYTES, SMOOTH MUSCLE; OVALBUMIN; PLATELET-DERIVED GROWTH FACTOR; PRIMARY CELL CULTURE; PROTEIN TRANSPORT; RESPIRATORY HYPERSENSITIVITY;

EID: 84880418935     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1425     Document Type: Article

References (60)

1. Bateman ED: Global strategy for asthma management and prevention 2009 (update). Report of Global Initiative for Asthma 2009: 2, 2009.
2. Girodet PO, Ozier A, Bara I, Tunon de Lara JM, Marthan R and Berger P: Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol Ther 130: 325-337, 2011.
3. Delacourt C: Bronchial changes in untreated asthma. Arch Pediatr 11 (Suppl 2): 71s-73s, 2004 (In French).
4. Black JL, Roth M, Lee J, Carlin S and Johnson PR: Mechanisms of airway remodeling. Airway smooth muscle. Am J Respir Crit Care Med 164: S63-S66, 2001.
5. Chung KF: The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 347-354, 2005.
6. Siddiqui S, Redhu NS, Ojo OO, et al: Emerging airway smooth muscle targets to treat asthma. Pulm Pharmacol Ther 26: 132-144, 2012.
7. Bar-Sela G, Epelbaum R and Schaffer M: Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem 17: 190-197, 2010.
8. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: an 'old-age' disease with an 'age-old' solution. Cancer Lett 267: 133-164, 2008.
9. Schaffer M, Schaffer PM, Zidan J and Bar Sela G: Curcuma as a functional food in the control of cancer and inflammation. Curr Opin Clin Nutr Metab Care 14: 588-597, 2011.
10. Ammon HP and Wahl MA: Pharmacology of Curcuma longa. Planta Med 57: 1-7, 1991.
11. Hatcher H, Planalp R, Cho J, Torti FM and Torti SV: Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652, 2008.
12. Aggarwal BB and Harikumar KB: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41: 40-59, 2009.
13. Yang X, Thomas DP, Zhang X, et al: Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol 26: 85-90, 2006.
14. Wong TF, Takeda T, Li B, et al: Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. Gynecol Oncol 122: 141-148, 2011.
15. Laporte JC, Moore PE, Baraldo S, et al: Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164: 141-148, 2001.
16. Weng SH, Tsai MS, Chiu YF, Kuo YH, Chen HJ and Lin YW: Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression. Basic Clin Pharmacol Toxicol 110: 298-306, 2012.
17. Saab MB, Bec N, Martin M, et al: Differential effect of curcumin on the nanomechanics of normal and cancerous mammalian epithelial cells. Cell Biochem Biophys 65: 399-411, 2012.
18. Dhandapani KM, Mahesh VB and Brann DW: Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 102: 522-538, 2007.
19. Yang CL, Liu YY, Ma YG, et al: Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One 7: e37960, 2012.
20. Chen JW, Tang YL, Liu H, et al: Anti-proliferative and anti-metastatic effects of curcumin on oral cancer cells. Hua Xi Kou Qiang Yi Xue Za Zhi 29: 83-86, 2011 (In Chinese).
21. Peterson TE, Guicciardi ME, Gulati R, et al: Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23: 1521-1527, 2003.
22. Luo DX, Cheng J, Xiong Y, et al: Static pressure drives proliferation of vascular smooth muscle cells via caveolin-1/ERK1/2 pathway. Biochem Biophys Res Commun 391: 1693-1697, 2010.
23. Qin L, Yang YB, Tuo QH, et al: Effects and underlying mechanisms of curcumin on the proliferation of vascular smooth muscle cells induced by Chol:MbetaCD. Biochem Biophys Res Commun 379: 277-282, 2009.
24. McMillan SJ and Lloyd CM: Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 34: 497-507, 2004.
25. Lloyd CM, Gonzalo JA, Nguyen T, et al: Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol 166: 2033-2040, 2001.
26. Hamelmann E, Schwarze J, Takeda K, et al: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766-775, 1997.
27. Chen G and Khalil N: TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res 7: 2, 2006.
28. Tang ML, Wilson JW, Stewart AG and Royce SG: Airway remodelling in asthma: current understanding and implications for future therapies. Pharmacol Ther 112: 474-488, 2006.
29. Nath P, Leung SY, Williams A, et al: Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur J Pharmacol 544: 160-167, 2006.
30. Oh SW, Cha JY, Jung JE, et al: Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition. J Ethnopharmacol 136: 414-421, 2011.
31. Moon DO, Kim MO, Lee HJ, et al: Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochem Biophys Res Commun 375: 275-279, 2008.
32. Karaman M, Firinci F, Cilaker S, et al: Anti-inflammatory effects of curcumin in a murine model of chronic asthma. Allergol Immunopathol (Madr) 40: 210-214, 2012.
33. Venkatesan N, Punithavathi D and Babu M: Protection from acute and chronic lung diseases by curcumin. Adv Exp Med Biol 595: 379-405, 2007.
34. Sharafkhaneh A, Velamuri S, Badmaev V, Lan C and Hanania N: The potential role of natural agents in treatment of airway inflammation. Ther Adv Respir Dis 1: 105-120, 2007.
35. Nel AE: T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol 109: 758-770, 2002.
36. Jacob A, Cooney D, Pradhan M and Coggeshall KM: Convergence of signaling pathways on the activation of ERK in B cells. J Biol Chem 277: 23420-23426, 2002.
37. Gauld SB, Dal Porto JM and Cambier JC: B cell antigen receptor signaling: roles in cell development and disease. Science 296: 1641-1642, 2002.
38. Nadler MJ, Matthews SA, Turner H and Kinet JP: Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv Immunol 76: 325-355, 2000.
39. Duan W, Chan JH, Wong CH, Leung BP and Wong WS: Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 172: 7053-7059, 2004.
40. De S, Zelazny ET, Souhrada JF and Souhrada M: Role of phospholipase C and tyrosine kinase systems in growth response of human airway smooth muscle cells. Am J Physiol 270: L795-L802, 1996.
41. Walker TR, Moore SM, Lawson MF, Panettieri RA Jr and Chilvers ER: Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation. Mol Pharmacol 54: 1007-1015, 1998.
42. Kumar A, Lnu S, Malya R, et al: Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma. FASEB J 17: 1800-1811, 2003.
43. Chiou YL, Shieh JJ and Lin CY: Blocking of Akt/NF-kappaB signaling by pentoxifylline inhibits platelet-derived growth factor-stimulated proliferation in Brown Norway rat airway smooth muscle cells. Pediatr Res 60: 657-662, 2006.
44. Bai J, Liu XS, Xu YJ, Zhang ZX, Xie M and Ni W: The effect of ERK signaling pathway on cell apoptosis in airway smooth muscle cells of chronic asthmatic rats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26: 738-741, 2010 (In Chinese).
45. Schlegel A, Volonte D, Engelman JA, et al: Crowded little caves: structure and function of caveolae. Cell Signal 10: 457-463, 1998.
46. Shaul PW and Anderson RG: Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275: L843-L851, 1998.
47. Anderson RG: The caveolae membrane system. Annu Rev Biochem 67: 199-225, 1998.
48. Okamoto T, Schlegel A, Scherer PE and Lisanti MP: Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
49. Couet J, Belanger MM, Roussel E and Drolet MC: Cell biology of caveolae and caveolin. Adv Drug Deliv Rev 49: 223-235, 2001.
50. Razani B, Woodman SE and Lisanti MP: Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467, 2002.
51. Schubert W, Frank PG, Woodman SE, et al: Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277: 40091-40098, 2002.
52. Ramirez MI, Pollack L, Millien G, Cao YX, Hinds A and Williams MC: The alpha-isoform of caveolin-1 is a marker of vasculogenesis in early lung development. J Histochem Cytochem 50: 33-42, 2002.
53. Thyberg J: Caveolin-1 and caveolae act as regulators of mitogenic signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 1481-1483, 2003.
54. Miyawaki-Shimizu K, Predescu D, Shimizu J, Broman M, Predescu S and Malik AB: siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am J Physiol Lung Cell Mol Physiol 290: L405-L413, 2006.
55. Gosens R, Stelmack GL, Dueck G, et al: Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 291: L523-L534, 2006.
56. Sun Y, Hu G, Zhang X and Minshall RD: Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ Res 105: 676-685, 615 p following 685, 2009.
57. Feng H, Guo L, Song Z, et al: Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis. J Biol Chem 285: 25154-25160, 2010.
58. Buitrago C and Boland R: Caveolae and caveolin-1 are implicated in 1α,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. J Steroid Biochem Mol Biol 121: 169-175, 2010.
59. Park JH, Ryu JM and Han HJ: Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways. J Cell Physiol 226: 267-275, 2011.
60. Watson CS, Jeng YJ, Hu G, Wozniak A, Bulayeva N and Guptarak J: Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I. Steroids 77: 424-432, 2012.